Wall Street Analysts Predict a 44.2% Upside in Novo Nordisk (NVO): Here's What You Should Know

Shares of Novo Nordisk (NVO) have gained 2.9% over the past four weeks to close the last trading session at $80.15, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $115.58 indicates a potential upside of 44.2%.The average comprises six short-term price targets ranging from a low of $65 to a high of $160, with a standard deviation of $37.31. While the lowest estimate indicates a ...